Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction
Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
The incidence of cardiovascular disease is still high in China under the condition of
non-standard treatment of Western medicine. Acute coronary plaque rupture and thrombosis is
an extreme manifestation of instability of "vulnerable plaque", which is the result of the
joint action of multiple factors. The intervention of unstable plaque reversal from multiple
factors is inherently reasonable. Compared with the treatment of thrombosis and unstable
plaque in western medicine, quick acting Jiuxin Pill can not only calm and relieve pain for
pain and other symptoms, but also regulate immune inflammation and metabolic disorder,
improve microcirculation and anti myocardial ischemia. In order to evaluate the efficacy,
safety and modern scientific basis of Suxiao Jiuxin Pill in acute myocardial infarction
(AMI), the investigators designed this study.